{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:04:09Z","timestamp":1777467849044,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BD"],"published-print":{"date-parts":[[2019,6,26]]},"DOI":"10.3233\/bd-180365","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T11:46:08Z","timestamp":1557229568000},"page":"47-55","source":"Crossref","is-referenced-by-count":5,"title":["Inflammatory breast cancer: A review from our experience"],"prefix":"10.1177","volume":"38","author":[{"given":"Marco","family":"Mele","sequence":"first","affiliation":[{"name":", Aarhus University Hospital, , , , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Schmidt","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":", Aarhus University Hospital, , , , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Bruun","sequence":"additional","affiliation":[{"name":", Aarhus University Hospital, , , , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas Amstrup","family":"Funder","sequence":"additional","affiliation":[{"name":", Aarhus University Hospital, , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine","family":"Tramm","sequence":"additional","affiliation":[{"name":", Aarhus University Hospital, , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Bodilsen","sequence":"additional","affiliation":[{"name":", Aarhus University Hospital, , , , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Melgaard","family":"Nielsen","sequence":"additional","affiliation":[{"name":", Aarhus University Hospital, , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peer M.","family":"Christiansen","sequence":"additional","affiliation":[{"name":", Aarhus University Hospital, , , , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"13","key":"10.3233\/BD-180365_ref1","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","article-title":"Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute","volume":"97","author":"Hance","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.3233\/BD-180365_ref2","first-page":"291","article-title":"Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program","volume":"74","author":"Levine","year":"1985","journal-title":"J Natl Cancer Inst"},{"issue":"109","key":"10.3233\/BD-180365_ref3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-007-9671-z","article-title":"Inflammatory breast cancer: PET\/CT, MRI, mammography, and sonography findings","author":"Yang","year":"2008","journal-title":"Breast Cancer Res Treat,"},{"issue":"4","key":"10.3233\/BD-180365_ref4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1245\/s10434-013-3439-y","article-title":"Incidence of inflammatory breast cancer in women, 1992\u20132009 United States","volume":"21","author":"Goldner","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.3233\/BD-180365_ref5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1634\/theoncologist.2012-0039","article-title":"Inflammatory breast cancer: what we know and what we need to learn","volume":"17","author":"Yamauchi","year":"2012","journal-title":"Oncologist"},{"key":"10.3233\/BD-180365_ref6","doi-asserted-by":"crossref","unstructured":"Mohamed MM, Al-Raawi D , Inflammatory breast cancer: new factors contribute to disease etiology: review, Journal of Advanced Research,2013.","DOI":"10.1016\/j.jare.2013.06.004"},{"issue":"6","key":"10.3233\/BD-180365_ref7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3322\/caac.20082","article-title":"Inflammatory breast cancer: the disease, the biology, the treatment","volume":"60","author":"Robertson","year":"2010","journal-title":"CA. Cancer J Clin"},{"issue":"4","key":"10.3233\/BD-180365_ref8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ijc.2910620404","article-title":"Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?","volume":"62","author":"Bonnier","year":"1995","journal-title":"Int J Cancer"},{"issue":"41","key":"10.3233\/BD-180365_ref9","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/1097-0142(197804)41:4<1595::AID-CNCR2820410450>3.0.CO;2-Y","article-title":"Inflammatory carcinoma of the breast","author":"Lucas","year":"1978","journal-title":"Cancer,"},{"key":"10.3233\/BD-180365_ref10","unstructured":"StataCorp, Stata Statistical Software: Release 12, no. College Station, 2011."},{"issue":"18","key":"10.3233\/BD-180365_ref11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jnci\/djt206","article-title":"Risk factors for inflammatory breast cancer and other invasive breast cancers","volume":"105","author":"Schairer","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.3233\/BD-180365_ref12","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10549-012-2133-2","article-title":"Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990\u20132008","volume":"134","author":"Schlichting","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.3233\/BD-180365_ref13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.breast.2012.02.002","article-title":"Primary chemo-radiotherapy in the treatment of locally advanced and inflammatory breast cancer","volume":"21","author":"Bates","year":"2012","journal-title":"Breast"},{"issue":"2","key":"10.3233\/BD-180365_ref14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.critrevonc.2014.09.003","article-title":"Inflammatory Breast Cancer: an Overview","volume":"93","author":"van Uden","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.3233\/BD-180365_ref15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0360-3016(02)04201-3","article-title":"Ten-year outcome after combined modality therapy for inflammatory breast cancer","volume":"55","author":"Harris","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3233\/BD-180365_ref16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/annonc\/mdq345","article-title":"International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment","volume":"22","author":"Dawood","year":"2011","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO"},{"issue":"2","key":"10.3233\/BD-180365_ref17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/0284186X.2015.1128119","article-title":"Improvements in breast cancer survival between 1995 and 2012 in Denmark: the importance of earlier diagnosis and adjuvant treatment","volume":"55","author":"Jensen","year":"2016","journal-title":"Acta Oncol"},{"issue":"4","key":"10.3233\/BD-180365_ref18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002800050664","article-title":"Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center","volume":"40","author":"Ueno","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.3233\/BD-180365_ref19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF00689090","article-title":"Inflammatory carcinoma of the breast: results of a combined-modality approach\u2013M. D. Anderson Cancer Center experience","volume":"27","author":"Koh","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"10.3233\/BD-180365_ref20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1055-3207(18)30426-5","article-title":"Combined modality treatment of stage III and inflammatory breast cancer. M. D. Anderson Cancer Center experience","volume":"4","author":"Buzdar","year":"1995","journal-title":"Surg Oncol Clin N Am"},{"issue":"5","key":"10.3233\/BD-180365_ref21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3816\/CBC.2004.n.042","article-title":"Long-term results of combined-modality therapy for inflammatory breast carcinoma","volume":"5","author":"Baldini","year":"2004","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"10.3233\/BD-180365_ref22","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/1097-0142(20011001)92:7<1775::AID-CNCR1693>3.0.CO;2-E","article-title":"Paclitaxel in the multimodality treatment for inflammatory breast carcinoma","volume":"92","author":"Cristofanilli","year":"2001","journal-title":"Cancer"},{"issue":"6","key":"10.3233\/BD-180365_ref23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3816\/CBC.2004.n.004","article-title":"Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience","volume":"4","author":"Cristofanilli","year":"2004","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.3233\/BD-180365_ref24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10434-999-0249-3","article-title":"Beyond palliative mastectomy in inflammatory breast cancer - A reassessment of margin status","volume":"6","author":"Curcio","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.3233\/BD-180365_ref25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijrobp.2008.01.039","article-title":"Locoregional treatment outcomes after multimodality management of inflammatory breast cancer","volume":"72","author":"Bristol","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.3233\/BD-180365_ref26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02573060","article-title":"Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer","volume":"9","author":"Stearns","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.3233\/BD-180365_ref27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BD-2006-22103","article-title":"Epidemiology of inflammatory breast cancer","volume":"22","author":"Anderson","year":"2005","journal-title":"Breast Dis"},{"issue":"1","key":"10.3233\/BD-180365_ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clbc.2014.05.005","article-title":"Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome","volume":"15","author":"Matro","year":"2014","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"10.3233\/BD-180365_ref29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2009.12.009","article-title":"Management of inflammatory breast cancer after neoadjuvant chemotherapy","volume":"79","author":"Abrous-Anane","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"0020-7136","key":"10.3233\/BD-180365_ref30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.2910430205","article-title":"Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance","volume":"43","author":"Guerin","year":"1989","journal-title":"Int J Cancer"},{"issue":"1","key":"10.3233\/BD-180365_ref31","first-page":"131","article-title":"Strong association between c-myb and oestrogen-receptor expression in human breast cancer","volume":"5","author":"Gu\u00e9rin","year":"1990","journal-title":"Oncogene"},{"issue":"2","key":"10.3233\/BD-180365_ref32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.breast.2003.08.004","article-title":"High incidence of HER-2 positi vity in inflammatory breast cancer","volume":"13","author":"Parton","year":"2004","journal-title":"Breast"},{"issue":"16","key":"10.3233\/BD-180365_ref33","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.3233\/BD-180365_ref34","doi-asserted-by":"crossref","unstructured":"Romond EH, Perez EA, Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer,, 353(16): 1673\u20131684, 2005.","DOI":"10.1056\/NEJMoa052122"},{"key":"10.3233\/BD-180365_ref35","doi-asserted-by":"crossref","unstructured":"Slamon DJ, Leyland-Jones B , Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2,, 344(11): 783\u2013792, 2001.","DOI":"10.1056\/NEJM200103153441101"},{"issue":"6","key":"10.3233\/BD-180365_ref36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1470-2045(14)70080-4","article-title":"Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort","volume":"15","author":"Gianni","year":"2014","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.3233\/BD-180365_ref37","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/annonc\/mdm060","article-title":"Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer","volume":"18","author":"Cabioglu","year":"2007","journal-title":"Ann Oncol"},{"issue":"4","key":"10.3233\/BD-180365_ref38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semradonc.2009.05.008","article-title":"Inflammatory breast cancer","volume":"19","author":"Woodward","year":"2009","journal-title":"Seminars in Radiation Oncology"}],"container-title":["Breast Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BD-180365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:31:58Z","timestamp":1777383118000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BD-180365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":38,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/bd-180365","relation":{},"ISSN":["0888-6008","1558-1551"],"issn-type":[{"value":"0888-6008","type":"print"},{"value":"1558-1551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]}}}